Systemic lupus erythematosus

Last updated: June 18, 2025

Systemic lupus erythematosus

B10

B10

Bacterial structure and functions
Staphylococcus epidermidis
Staphylococcus saprophyticus
Staphylococcus aureus
Streptococcus viridans
Streptococcus pyogenes (Group A Strep)
Streptococcus pneumoniae
Streptococcus agalactiae (Group B Strep)
Enterococcus
Inflammation
Wound healing
Sepsis
Abscesses
Neonatal sepsis
Thymus histology
Spleen histology
Lymph node histology
Introduction to the immune system
Cytokines
Innate immune system
Complement system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Somatic hypermutation and affinity maturation
VDJ rearrangement
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Anergy, exhaustion, and clonal deletion
Vaccinations
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Common variable immunodeficiency
IgG subclass deficiency
Hyperimmunoglobulin E syndrome
Isolated primary immunoglobulin M deficiency
Thymic aplasia
DiGeorge syndrome
Severe combined immunodeficiency
Adenosine deaminase deficiency
Ataxia-telangiectasia
Hyper IgM syndrome
Wiskott-Aldrich syndrome
Leukocyte adhesion deficiency
Chediak-Higashi syndrome
Chronic granulomatous disease
Complement deficiency
Hereditary angioedema
Asplenia
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Glucocorticoids
Introduction to the lymphatic system
Skin histology
Skin anatomy and physiology
Hair, skin and nails
Burns: Clinical
DNA structure
DNA replication
Transcription of DNA
DNA damage and repair
Translation of mRNA
Zika virus
Herpes simplex virus
Herpesvirus medications
Epstein-Barr virus (Infectious mononucleosis)
Influenza virus
Poliovirus
Rubella virus
Parvovirus B19
Rotavirus
Norovirus
Adenovirus
Viral structure and functions
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Gastroenteritis
Bacterial epiglottitis
Helicobacter pylori
Neisseria gonorrhoeae
Varicella zoster virus
Food allergy
Anaphylaxis
Asthma
Immune thrombocytopenia
Autoimmune hemolytic anemia
Hemolytic disease of the newborn
Rheumatic heart disease
Myasthenia gravis
Graves disease
Pemphigus vulgaris
Serum sickness
Systemic lupus erythematosus
Poststreptococcal glomerulonephritis
Graft-versus-host disease
Contact dermatitis
Transplant rejection
Cytomegalovirus infection after transplant (NORD)
Post-transplant lymphoproliferative disorders (NORD)
Thymoma
Ruptured spleen
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Antituberculosis medications
Meningitis, encephalitis and brain abscesses: Clinical
Pneumonia
DNA synthesis inhibitors: Fluoroquinolones
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
Mechanisms of antibiotic resistance
Monoclonal antibodies
Mycoplasma pneumoniae
Pneumonia: Pathology review
Haemophilus influenzae
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Chlamydia pneumoniae
Meningitis
Neisseria meningitidis
Escherichia coli
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Shigella
Clostridium difficile (Pseudomembranous colitis)
Clostridium botulinum (Botulism)
Azoles
ELISA (Enzyme-linked immunosorbent assay)
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Blood groups and transfusions
Blood products and transfusion: Clinical
Anti-tumor antibiotics
Sexually transmitted infections: Clinical

Transcript

Watch video only

Content Reviewers

Alright, “systemic lupus erythematosus,” k we totally got this. “Systemic” is easy, and refers to affecting multiple organs in the body.

“Erythematosus” means reddening of the skin, alright alright.

Lupus” is latin for “wolf”. So affects multiple organs wolf...reddening of the skin?

Not exactly, the modern use of lupus usually refers to a variety of diseases that affect the skin...which was possibly originally used since these diseases resemble a wolf bite on the patients’ skin.

Is that true? Who knows. At any rate, systemic lupus erythematosus, or SLE, sometimes just lupus, is a disease that’s systemic, and affects a wide variety of organs, but notably often causes red lesions on the skin.

But how does lupus affect all these organs? Well usually the immune system protects the body’s tissues from invaders, but lupus is an autoimmune disease, which means that immune cells start attacking the very tissues their supposed to protect.

With lupus, essentially any tissue or organ can be targeted.

And just like a ton of other autoimmune diseases though, it’s not completely clear why it develops, and like most diseases it’s the result of both genetics and the environment.

Alright so let’s go over a specific scenario to show how this plays out.

Let’s say this guy has susceptibility genes—genes that make him susceptible to getting lupus, and he’s exposed to UV radiation in sunlight, which we know is an environmental risk factor for lupus.

Well, given enough UV rays, think like sunburn, the cell’s DNA can become so badly damaged, that the cell undergoes programmed cell death, or apoptosis, and it dies.

This produces all these little apoptotic bodies, and exposes the insides of the cell, including parts of the nucleus, like DNA, histones, and other proteins, to the rest of the body.

Well those susceptibility genes specifically have an effect on this person’s immune system such that their immune cells are more likely to think that these are foreign, or antigens, and since they’re from the nucleus, we call them nuclear antigens, and immune cells try to attack them.

Not only that though, susceptibility genes also cause this person to have less effective clearance, essentially they aren’t as good at getting rid of the apoptotic bodies and so they end up having more nuclear antigens floating around.

This means that B cells might swing by, see them, and start the production of antibodies against these pieces of nucleus, which are called antinuclear antibodies, and these guys are present in almost all cases of lupus.

Alright so those antinuclear antibodies bind to the nuclear antigens, forming antigen-antibody complexes.

These complexes can get into the blood and then drift away and deposit or stick to the vessel wall in all sorts of different organs and tissues like the kidneys, skin, joints, heart.

Deposited complexes then initiate a local inflammatory reaction, which causes damage through the activation of the complement system, which, after a huge cascade of enzyme activation, leaves cell membranes with channels that let fluid and molecules go in and out all willy nilly, causing the cell to burst and die, usually though you’d want this to happen to foreign cell or an infected cell, not healthy cells.

When tissues become damaged as a result of these immune complexes, it’s known as a type III hypersensitivity reaction.

UV radiation isn’t the only way to damage cells, though, right?

It therefore isn’t the only trigger that’s thought to be associated with lupus—other potential triggers that have been associated with SLE include cigarette smoking, viruses, bacteria, use of certain medications like procainamide, hydralazine, and isoniazid, as well as sex hormones, particularly estrogen, which might be partly why lupus is more common in women, especially considering it’s about 10 times more common in women than men during reproductive years, but only about 2 or 3 times more common in childhood or past the age of 65.

Okay okay, as a quick recap, the model that’s generally thought to be what leads to SLE starts with some environmental trigger, which damages cells, and causes apoptosis and the release of nuclear antigens.

At this point, the genetic components come in, and the person likely has certain genes that make them not so good at clearing these apoptotic bodies and nuclear antigens, so you end up with a lot of nuclear antigens floating around.

In combination, they probably also have genes that cause their immune cells to recognize these nuclear antigens as foreign, which initiates an immune response, creates antinuclear antibodies that bind to antigens and then float around and deposit in various tissues, which causes inflammation.

These deposits and inflammation seem to be the cause of most of the symptoms of lupus, which remember is a type III hypersensitivity reaction.

Many patients, though, also develop antibodies targeting other cells like red and white blood cells, and molecules like various phospholipids, which can mark them for phagocytosis and destruction, leading to additional symptoms.

Key Takeaways

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease in which the body's immune system mistakenly attacks healthy tissue. SLE most often harms the heart, joints, skin, lungs, blood vessels, liver, kidneys, and nervous system. Common symptoms of SLE can include fatigue, joint pain, rash, fever, and anemia. The course of the disease is unpredictable, with periods of illness (called flare-ups) alternating with remissions. Treatment typically involves medications to manage symptoms, reduce inflammation, and suppress the immune system.